AstraZeneca holds talks with Bristol Myers Squibb on $400B megadeal: report
Business AstraZeneca holds talks with Bristol Myers Squibb on $400B megadeal: report By Reuters Published Aug. Add The New York Post on Google UK drugmaker AstraZeneca has been exploring a deal to combine with US rival Bristol Myers Squibb, the Financial Times reported on Sunday, citing people familiar with the matter. The deal could create one of the world’s biggest pharmaceutical groups with a combined value of nearly $400 billion.
- ▪Business AstraZeneca holds talks with Bristol Myers Squibb on $400B megadeal: report By Reuters Published Aug.
- ▪Add The New York Post on Google UK drugmaker AstraZeneca has been exploring a deal to combine with US rival Bristol Myers Squibb, the Financial Times reported on Sunday, citing people familiar with the matter.
- ▪The deal could create one of the world’s biggest pharmaceutical groups with a combined value of nearly $400 billion.
4 outlets in our directory ran this story, first to last over 10 hours. Coverage spans 2 points on the political spectrum — 1 lean left, 1 centre.
- ▪ AstraZeneca holds talks with Bristol Myers Squibb on $400bn merger — The Guardian — World
- ▪ AstraZeneca holds talks with Bristol Myers Squibb on $400 billion megadeal, FT reports - Reuters — Google News
- ▪ AstraZeneca holds talks with Bristol Myers Squibb over $400bn tie-up — International homepage
New York Post files mainly under news. We currently carry 11,009 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | New York Post |
| Canonical URL | https://nypost.com/2026/08/02/business/astrazeneca-holds-talks-with-bristol-myers-squibb-on-400b-megadeal-report/ |
| Publication time | Sun, 02 Aug 2026 17:40:08 -0400 |
| Retrieval time | 2026-08-02T22:57:03.437Z |
| Last seen | 2026-08-02T22:57:03.437Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | 0D428S38C0jP · 5 stories |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Business AstraZeneca holds talks with Bristol Myers Squibb on $400B megadeal: report By Reuters Published Aug. 2, 2026, 5:40 p.m. ET (function() { var overlay = document.getElementById("nyp-player-lcp-overlay"); if (!overlay) { return; } function hideOverlay() { overlay.remove(); } function afterDCL() { requestAnimationFrame(hideOverlay); } if (document.readyState === "loading") { document.addEventListener("DOMContentLoaded", afterDCL, { once: true }); } else { afterDCL(); } })(); See more of our coverage in your search results. Add The New York Post on Google UK drugmaker AstraZeneca has been exploring a deal to combine with US rival Bristol Myers Squibb, the Financial Times reported on Sunday, citing people familiar with the matter.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at New York Post.
Discussion
0 commentsMore from New York Post
